Canton Strategic Holdings (CNTN) Treasury Shares (2022 - 2026)
Canton Strategic Holdings posted quarterly Treasury Shares of $69965.0 for Q1 2026, little changed year-on-year from $69965.0 in Q1 2025, and little changed on a QoQ basis from $69965.0 in Q4 2025.
Canton Strategic Holdings (CNTN) has 5 years of Treasury Shares data on file, last reported at $69965.0 in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares changed 0.0% year-over-year to $69965.0; the trailing twelve-month figure through Mar 2026 stood at $69965.0 (changed 0.0% YoY), and the FY2025 full-year result was $69965.0, changed 0.0% from the prior year.
- Treasury Shares for Q1 2026 stood at $69965.0, roughly flat from $69965.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $90826.0 in Q1 2023 and bottomed at $246.0 in Q4 2023.
- The 5-year median for Treasury Shares is $246.0 (2023), against an average of $23980.0.
- Peak annual rise in Treasury Shares reached 183.22% in 2023, while the deepest fall reached 0.0% in 2023.
- A 5-year view of Treasury Shares shows it stood at $69965.0 in 2022, then changed by 0.0% to $69965.0 in 2023, then changed by 0.0% to $69965.0 in 2024, then changed by 0.0% to $69965.0 in 2025, then changed by 0.0% to $69965.0 in 2026.
- The last three Treasury Shares figures came in at $69965.0 (Q1 2026), $69965.0 (Q4 2025), and $69965.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | 246.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 246.00 |
| Mar 31, 2026 | 69,965.00 |
| Mar 31, 2026 | 246.00 |
| Mar 31, 2026 | 69,965.00 |
| Dec 31, 2025 | 69,965.00 |
| Dec 31, 2025 | 246.00 |
| Dec 31, 2025 | 246.00 |
| Dec 31, 2025 | 69,965.00 |
| Sep 30, 2025 | 246.00 |
| Sep 30, 2025 | 69,965.00 |
| Sep 30, 2025 | 69,965.00 |
| Sep 30, 2025 | 246.00 |
| Jun 30, 2025 | 246.00 |
| Jun 30, 2025 | 246.00 |
| Jun 30, 2025 | 69,965.00 |
| Jun 30, 2025 | 69,965.00 |
| Mar 31, 2025 | 69,965.00 |
| Mar 31, 2025 | 69,965.00 |
| Mar 31, 2025 | 246.00 |
| Mar 31, 2025 | 246.00 |
| Dec 31, 2024 | 246.00 |
| Dec 31, 2024 | 69,965.00 |
| Dec 31, 2024 | 246.00 |
| Dec 31, 2024 | 69,965.00 |
| Sep 30, 2024 | 69,965.00 |
| Sep 30, 2024 | 246.00 |
| Sep 30, 2024 | 69,965.00 |
| Sep 30, 2024 | 246.00 |
| Jun 30, 2024 | 69,965.00 |
| Jun 30, 2024 | 69,965.00 |
| Jun 30, 2024 | 246.00 |
| Jun 30, 2024 | 246.00 |
| Mar 31, 2024 | 246.00 |
| Mar 31, 2024 | 246.00 |
| Mar 31, 2024 | 69,965.00 |
| Mar 31, 2024 | 69,965.00 |
| Dec 31, 2023 | 69,965.00 |
| Dec 31, 2023 | 69,965.00 |
| Dec 31, 2023 | 246.00 |
| Dec 31, 2023 | 246.00 |
| Sep 30, 2023 | 90,826.00 |
| Sep 30, 2023 | 90,826.00 |
| Sep 30, 2023 | 69,965.00 |
| Sep 30, 2023 | 69,965.00 |
| Jun 30, 2023 | 69,965.00 |
| Jun 30, 2023 | 69,965.00 |
| Jun 30, 2023 | 90,826.00 |
| Jun 30, 2023 | 90,826.00 |
| Mar 31, 2023 | 69,965.00 |
| Mar 31, 2023 | 69,965.00 |
| Mar 31, 2023 | 90,826.00 |
| Mar 31, 2023 | 90,826.00 |
| Dec 31, 2022 | 69,965.00 |
| Dec 31, 2022 | 69,965.00 |
| Dec 31, 2022 | 3,633.00 |
| Dec 31, 2022 | 3,633.00 |
| Sep 30, 2022 | 75,109.00 |
| Sep 30, 2022 | 75,109.00 |
| Sep 30, 2022 | 62,147.00 |
| Sep 30, 2022 | 62,147.00 |
| Jun 30, 2022 | 30,000.00 |
| Jun 30, 2022 | 30,000.00 |
| Jun 30, 2022 | 24,703.00 |
| Jun 30, 2022 | 24,703.00 |